Mike Pyle, Global Chief Investment Strategist, together with Beata Harasim, Senior Investment Strategist, Kurt Reiman, Senior Strategist for North America, and Tara Sharma, Member of the Macro Research team, all part of the BlackRock Investment Institute, share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.
Corporate earnings estimates look to be troughing as economies reopen with fits and starts. We have increased our overweight in the quality factor because we see it as most resilient to the dynamics of a choppy activity restart, given its focus on companies with strong balance sheets and profitability. We also recently closed our underweight in cyclical assets, including upgrading the value factor to neutral.
The coronavirus shock dealt a historic shock to the real economy – and the biggest blow to corporate earnings since the 2008 financial crisis. Yet earnings revisions – or the ratio of upgrades to downgrades of corporate earnings estimates by analysts – look to have troughed in recent weeks. This is true across major regions, including emerging markets, as the chart above shows. Even the euro area (yellow line) – which saw the deepest trough – looks to have bottomed. The activity restart – one of the three key investment themes we explored in our Midyear Outlook – is a key reason for the increased optimism on the path of corporate earnings. To be sure, we expect this restart to be uneven over time and across regions. We see Europe as the most attractive exposure to a multi-speed global restart.
U.S. corporate earnings season is in full swing, with more than half of S&P 500 companies having delivered second-quarter scorecards. Roughly 80% of firms have beaten profit estimates, which had been slashed around 30% since January. Most sectors are seeing profits fall relative to a year ago, with energy earnings hardest hit. The tech and utilities sectors look on pace to register year-on-year earnings gains. Similar earnings trends are showing up in Europe and elsewhere. While the earnings cycle appears to have troughed, we believe consensus expectations for a return to 2019-level earnings next year may be overoptimistic. This points to downside risks if the activity restart is delayed – and policy stimulus fails to bridge households and businesses through the income shock. When assessing the impact of the shock on the economy, we focus on the cumulative GDP loss over time – or economic shortfall. Likewise, equity prices should reflect not just the near-term earnings outlook but the cumulative earnings loss versus the pre-virus trend. We expect this recovery to take several years.
Against this backdrop, we have increased the magnitude of our overweight in quality. We see quality companies – those with strong balance sheets, profitability and free cash flow – as those most resilient against the uncertainties in a multi-speed global economic restart. In addition, the factor includes many of the best-positioned companies in sectors such as tech, communication services and healthcare that are benefiting from secular growth trends that look to have been accelerated by the pandemic (think work from home). Many of these companies are found in the U.S. Yet we recently downgraded U.S. equities to neutral. Why? We previously preferred the U.S. for its strong policy response and quality bias. We still like the quality parts of the U.S. market, but have become more cautious overall due to a challenged public health backdrop and a risk of reduced fiscal policy support as key relief measures expire. This leads us to be increasingly cautious on broad U.S. exposures outside of those core quality holdings.
The differentiated global restart has also led us to close an underweight in cyclicality. This is reflected in our recent upgrade of the value factor to neutral – and a downgrade of min-vol to neutral. On a regional basis, we upgraded European equities to overweight and Japan to neutral from underweight, as we see these regions offering exposure to a cyclical uptick. Europe’s strengthened policy framework is another positive. What about momentum? The factor has outperformed in 2020 to date, but we stay neutral given that the fits-and-starts economic restart may challenge trending exposures.
Activity has started to normalize in both Europe and North Asia, albeit with localized lockdowns to contain virus clusters. The pandemic is still spreading in the U.S. and many emerging markets. The unprecedented policy response has boosted risk assets. Europe has agreed on a historic recovery fund, but U.S. stimulus is now at risk of fading. Wrangling over the size and makeup of a new U.S. fiscal package is intensifying as key benefits expire and states face huge budget shortfalls. We could see a $1-1.5 trillion fiscal package that extends some (but not all) federal stimulus measures through late-2020.
The U.S. monthly jobs report will be a major highlight as the country faces a fiscal cliff, with one key stimulus measure – an emergency extension of unemployment benefits – expiring. Congress still looks far from reaching a comprehensive deal but we could see a $1-1.5 trillion fiscal package that extends some federal stimulus measures through late-2020. Also in focus: Democratic presidential nominee Joe Biden is expected to unveil his pick for vice-presidential running mate.
BlackRock's Key risks & Disclaimers:
This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of August 3rd, 2020 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.
The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets.
Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.
This information has been accurately reproduced, as received from BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.
The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment and may be deducted from the invested amount therefore lowering the size of your investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.